Back to search
Obstructive Sleep Apnea, Obesity
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Obstructive Sleep Apnea, Obesity trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Obstructive Sleep Apnea, Obesity trials you may qualify forThis Phase 3 clinical trial is designed to evaluate the efficacy and safety of maridebart cafraglutide compared to placebo over a 52-week period in adults with…
This Phase 3 clinical trial is designed to evaluate the efficacy and safety of maridebart cafraglutide compared to placebo over a 52-week period in adults with…
The purpose of the studies is to evaluate the efficacy and safety of eloralintide in participants with moderate-to-severe obstructive sleep apnea and obesity or…
The aim of the study is to assess the efficacy and safety of XW003 injections in obese participants with OSA but not receiving PAP
The aim of the study is to assess the efficacy and safety of XW003 injections in obese participants with OSA receiving PAP
glaucoma is prevalent among obstructive sleep apnea (OSA). contnous passive airway pressure is main treatment of OSA. lifestyle corrections also recommended
The goal of the study is to compare deoxygenation events during anesthesia induction and mask ventilation when using standard oral pharyngeal airways or the nov…
This study is being done to look at the efficacy and safety of NNC0487-0111 in participants with excess body weight and obstructive sleep apnoea not treated wit…
This study is being done to look at the efficacy and safety of NNC0487-0111 in participants with overweight or obesity, and obstructive sleep apnoea treated wit…